Advertisement
Screener

NATERA, INC. (NTRA) Overview

NATERA, INC. (NTRA) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.47; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.60; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.64; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.74; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$173.52$208.56$250.67$301.29$362.12$435.252025-11-062026-11-06$26.72$46.69$81.59$142.56$249.10$435.252021-11-082026-11-06$7.13$16.22$36.91$84.01$191.23$435.252016-11-072026-11-06$6.28$14.66$34.22$79.88$186.45$435.252015-07-012026-11-06$6.28$14.66$34.22$79.88$186.45$435.252015-07-012026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$310.78
Previous close
$414.52
Change
-$103.74
Change (%)
-25.03%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

NTRA
+80.94%
S&P 500
(m)

1 year

NTRA
+154.17%
S&P 500
(m)

3 years

NTRA
+836.77%
S&P 500
(m)

5 years

NTRA
+285.17%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.47

-0.82-0.69-0.55-0.42-0.2931 Mar 2025: estimate (m); actual -0.5031 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.7430 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.6430 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.6031 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.4730 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.47(m)(m)
1 Jan 202631 Mar 2026(m)-0.60(m)(m)
1 Jul 202530 Sept 2025(m)-0.64(m)(m)
1 Apr 202530 Jun 2025(m)-0.74(m)(m)
1 Jan 202531 Mar 2025(m)-0.50(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.52

-5.65-4.57-3.50-2.42-1.3431 Dec 2021: estimate (m); actual -5.2131 Dec 2021(m)31 Dec 2022: estimate (m); actual -5.5731 Dec 2022(m)31 Dec 2023: estimate (m); actual -3.7831 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.5331 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.5231 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.52(m)(m)
1 Jan 202431 Dec 2024(m)-1.53(m)(m)
1 Jan 202331 Dec 2023(m)-3.78(m)(m)
1 Jan 202231 Dec 2022(m)-5.57(m)(m)
1 Jan 202131 Dec 2021(m)-5.21(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 752.75M ■ Earnings -66.97M — Profit margin -8.90%

-188.38M-15.8%158.94M-7.8%506.26M0.1%853.59M8.1%30 Sept 2025: revenue 592.18M; earnings -87.54M; profit margin -14.78%30 Sept 202531 Dec 2025: revenue 665.50M*; earnings 47.26M*; profit margin 7.10%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 696.64M; earnings -85.09M; profit margin -12.21%31 Mar 202630 Jun 2026: revenue 752.75M; earnings -66.97M; profit margin -8.90%30 Jun 2026

31 Dec 2025 ■ Revenue 2.31B ■ Earnings -0.21B — Profit margin -9.03%

-0.89B-67.8%0.29B-47.9%1.47B-27.9%2.65B-8.0%31 Dec 2022: revenue 0.82B; earnings -0.55B; profit margin -66.79%31 Dec 202231 Dec 2023: revenue 1.08B; earnings -0.43B; profit margin -40.16%31 Dec 202331 Dec 2024: revenue 1.70B; earnings -0.19B; profit margin -11.22%31 Dec 202431 Dec 2025: revenue 2.31B; earnings -0.21B; profit margin -9.03%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$310.78(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$310.78High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning NTRA

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-192.35M
Profit margin
-7.11%
Return on assets · 12 month
-8.71%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.53M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
6.04%*
Total return · month
27.05%*
Total return · quarter
52.22%*
Total return · half year
126.95%*
Total return · year to date
80.94%*
Total return · 1 year
154.17%*
Total return · 3 years
836.77%*
Total return · 5 years
285.17%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$2.71B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

NATERA, INC. Overview

View more →

(m)

(m)

SEC CIK
1604821
Industry (SIC)
8071 Services-Medical Laboratories
Country of operation
United States
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, Texas, 78753, United States
Fiscal year end
1231
Phone
650-249-9090

Similar stocks

Stock NameCountryMarket CapPE Ratio
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43